Home / Publication / A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

刊物

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

Author(s): Laetitia Canini, Annabelle Lemenuel-Diot, Barbara J. Brennan, Patrick F. Smith, Alan S. Perelson

Year: 2017 年 1 月 10 日

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

视频

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

释放寡核苷酸疗法的力量：与 Certara 和 Ionis 合作，采用基于模型的方法

计算 AUC（线性和对数线性）

累积：含义和计算方法

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

订阅时事通讯

快捷链接

解决方案

联系我们